ʻO ka Dyslipidemia kahi maʻi i loko o nā hoʻohālikelike o nā pōkole o nā koloka like ʻole, ʻaʻole i hōʻike ʻia e nā maʻi kulekele kikoʻī. Akā, he mea hoʻonāukiuki ia i ka hoʻomohala ʻana i nā ʻano ʻaoʻao like ʻole i ke kino o ke kanaka.
Mai kēia mai ua ʻike ʻia ka dyslipidemia, me kahi maʻi kūʻokoʻa, ʻaʻole i ʻike ʻia e nā poʻe loea, akā he "provocateur" e pili ana i ka hanana ʻana o kahi palala maʻi i kapa ʻia "atherosclerotic vascular lesion".
ʻO ka hanaʻinoʻole o kahi ʻano dyslipidemic e hiki pinepine ai i ka lawe ʻana i nā waihona momona ma luna o nā paia o nā moku. Ma muli o kēia, ka lilo ʻole o ke kahe o ke koko ma ka moʻo o ka moena a lilo i hōʻino ka hemodynamic i nā pānaʻi a me nā ʻāpana.
Nā kumu kumu o ka maʻi
Hiki i ka Dyslipidemia ke ʻano ma lalo o nā ʻano ʻano like ʻole, me ka laʻana, me nā pilikia i hele pū ʻia me ka hoʻōla ʻana o ka synt synt fatty, a me ka pā nui o ka momona mai ka meaʻai.
Eia kekahi, ʻo kahi palupalu ma ka hoʻohālikelike o ka hapa o nā momona momona e hiki ke hoʻoulu ʻia e ka maʻa o ke kīhai ʻana i kā lākou wehe a haʻalele. Hiki i kēia ke hiki i kahi mea liʻiliʻi o nā momona i loko o ke kino me ka meaʻai.
I mea e like ai me ka hoʻolālā o ka pathogenetic o ka hoʻomohala ʻana o ka ʻolima dyslipidemic, aia kekahi mau ʻano o ka etiopathogenetic dyslipidemia. Pono loa nā ʻano heʻumi āpau o ka dyslipidemia i loko o nā puka mua a ua hoʻokaʻawale ʻia i ka monogen a me polygenic.
- Hōʻike ʻia nā ʻano monogen e ka hoʻomohala ʻana o ka maʻi dyslipidemia ma muli o ka loaʻa ʻana o ka hua a maikaʻiʻole e kahi keiki mai kekahi o nā mākua e ʻeha nei i kēia ʻano kuʻuna, a i ʻole nā manawa ʻelua.
- Hoʻoholo ka polygenic hoʻomohala o ka dyslipidemia ma o ka hoʻoilina ʻana o ka gen maikaʻi ʻole, akā, ma ka hopena maikaʻi o ke kaiapuni.
Nui! ʻO ka paʻakikī o ka dyslipidemia ka mea paʻakikī loa e hoʻohālikelike ʻia, no ka mea, ʻo ka hiki ʻana o kēia alahele ma muli o nā maʻi maʻi āpau i loaʻa i ka mea maʻi.
ʻO nā maʻi nui e hiki ai ke hoʻonāukiuki i kēia a i ʻole kēlā ʻano ʻano o ka pathogenetic dyslipidemia:
- diabetes mellitus;
- hypothyroidism;
- nā ʻano maʻi āpau ʻole.
Hoʻokumu ʻia ka diagnagopa ʻo "alimentary dyslipidemia" i hōʻike ʻia i hōʻike ʻia ʻo ka mea nui o ka koloa o ka kolamu me ka meaʻai. ʻO kēlā ʻano ʻano o ka dyslipidemia hiki ke transient, kahi e ala hou ai ke kolamu no kahi manawa pōkole wale nō, a no kēia mea i ka hoʻohana ʻana i kahi nui o nā meaʻai momona.
I ka nui o nā hihia, hōʻike wale ʻia ka dyslipidemia me he hoʻonui lōʻihi o nā kuʻuna o ka cholesterol ma ke kahawai. A ʻoiai he mea nui ka manaʻo nui o nā kānaka a puni ka honua.
ʻĀmaʻomaʻo
Hoʻololi ʻia ka Dyslipidemia ma ka laboratorium. No kēia kumu, hiki ke kiʻi ʻia kahi maʻi e pili ana i ka hōʻike ʻoihana. Ma muli o kēia, ʻaʻole noho nā hōʻailona maʻi i kahi kūlana alakaʻi.
ʻO ka poʻe loea loea, akā, me ka nānā ʻike ʻia o ka maʻi maʻi i hoʻomanawanui i ka maʻi dyslipidemia no ka manawa lōʻihi, hiki paha ke kānalua i ka maʻi. Kēia mau ʻōmaʻomaʻo ʻano ākea i loaʻa xanthomas - nā wili liʻiliʻi ma ka ʻili. ʻO nā wahi punahele no ka hoʻokae ʻana o nā xanthomas;
- ke keke o na wawae;
- nā kuli a me nā lima;
- kiko o kahi o ke kua.
ʻO ka hōʻiliʻili nui o ka kolamu, ka mea i hōʻike ʻia i nā ʻano o nā ʻano like ʻole, ka ukali ʻia e ka hiʻohiʻona o xanthelasm. ʻO kēia nā neoplasms melemele o nā ʻano like ʻole, e loaʻa ana ma nā maka. Loaʻa ka Xanthelasms i kahi kikowaena paʻakikī, a ʻo kā lākou kiko kiko'ī he kolesterol.
Me ke ʻano hoʻoilina o ka dyslipidemia, loaʻa kahi lipoid o ka kornea. ʻO kahi rima keʻokeʻo kēia e kū ana ma ka ʻaoʻao o waho o ka korne.
ʻOiai ka ʻilihune o nā hōʻike maʻi lapaʻau, hiki i ka maʻi ke hoʻololi i ka dyslipidemia a hiki i kahi pae outpatient. Hoʻokomo kēia ʻōpili i nā noiʻi o nā ʻōiwi like ʻole.
ʻO ka nānā ʻana o ka ʻenehana nui maʻamau i kēia lā, ka ʻikepili o ka mea i manaʻoʻia e ka mea loea i ka wā e nānā ai i ka "dyslipidemia", ʻo ia ka lipid o ka mea maʻi. Ma kēia ʻano i ka manaʻo:
- ka hoʻoholoʻana o ke kālai ʻana o nā hoʻolaʻa kolala;
- ka hoʻoholo o ka waiwai o ka atherogenicity.
Hōʻike kēia mau mea ʻelua i kahi pilikia nui loa o ka maʻi atherosclerotic ma kahi maʻi. Ma muli o ka nui o ka nui o nā ʻano lapaʻau o dyslipidemia he ʻano hoʻoilina mōʻolelo, i kēia lā he loiloi genetic o nā poʻe maʻi me ka hoʻākāka ʻana o kahi ʻano o nā huaʻōlelo hewa i ka loiloi maʻamau. Eia kekahi, hiki iā ʻoe ke hoʻohana i ka mea hana no ke ana ʻana i ka cholesterol a lawe i nā ana ʻana ma ka home.
Nā maʻi maʻi
Kahi ʻia ka papa honua o nā maʻi i ka manaʻo e pili ana ka nui o nā iki o nā momona i ke koko o ka mea maʻi. Hoʻokaʻawale ʻia nā dyslipidemia āpau a hoʻokaʻawale ʻia.
- Hoʻomoe ʻia - ʻo ia mau mea kahi e hoʻonui ai nā hōʻailona o ka lipoproteins, he mau mea kuʻuna i ka kolamu.
- Hoʻohui - me kēia mau dyslipidemia, kahi hoʻohui i ka cholesterol, ka piʻi nui ʻana o ka triglycerides.
ʻO kahi koho e ʻoi aku ana no ka wehe ʻana i ka dyslipidemia ma ka ʻano o Fredrickson, e like me kēia ʻano mahele ʻia i ka ʻelima mau ʻano.
- Hereditary primer hyperchilomicronemia, kahi ʻano like ʻole 1 dyslipidemia. Hoʻolima ʻia ka maʻi e ka piʻi ʻana o ka piʻi ʻana o nā chylomicrons, nona ka 90% o nā triglycerides a me 10% o ka cholesterol. Paipai ia ʻo kēia ʻano like ʻole o ka dyslipidemia hiki ʻole ke lilo i kumu nui no ka hoʻomohala ʻana i nā maʻi o ka atherosclerotic o nā puʻuwai a me nā koko.
- Hoʻohālikelike ʻia ka lua o ke ʻano o ka dyslipidemia ma o ka hoʻonui ʻana i nā hōʻailona o ka lipoproteins haʻahaʻa haʻahaʻa e pili ana i nā ʻāpana o ka kolamu me kahi kiʻekiʻe o ka atherogenicity. ʻO kēia ʻano maʻi ka polygenic, ʻoiai i ka hiki ʻana mai o ka hoʻoluʻu dyslipidemic e pono ai ka hui pū ʻana me nā hua i hoʻopuka i ka hua lahilahi a me nā pōʻino pili kaiapuni. ʻO kahi hiʻohiʻona kaʻawale o ka type 2 o ka dyslipidemia ka mea i kū ai ka mea maʻi ʻaʻole wale i ka pae o nā lipoproteins haʻahaʻa haʻahaʻa, akā i ka pae o ka triglycerides.
- ʻO ke kolu o ke ʻano o ka dyslipidemia e hōʻike ʻia e ka mea i ka mea maʻi o kahi hōʻailona kiʻekiʻe o nā lipoproteins o ka haʻahaʻa haʻahaʻa haʻahaʻa, ua hele pū ʻia me ka mea nui o ka ʻāleʻa o ka atherosclerotic vascular.
- Me ka helu ʻehā, ʻike pū ʻia ka nui o ka pae o ka lipoproteins haʻahaʻa haʻahaʻa. Akā i kēia hihia, ulu ke kūlana ʻaʻole no ka mea o nā mea hoʻoilina, akā no nā kumu endogenous.
- ʻO ka lima ʻelima o ka dyslipidemia ka hoʻonui i ka nui o nā chylomicrons i loko o ke koko, i hui pū ʻia me ka hoʻonui ʻana o ka nui o nā lipoproteins haʻahaʻa haʻahaʻa.
Ma muli o nā ʻano ʻano like ʻole o ka maʻi dyslipidemic ma ka papa honua, aia kekahi mau ʻano o kēia ʻano kuʻuna. Eia naʻe, no ka 10 mcb dyslipidemia pākahi helu helu E78.
Hoʻomaʻamaʻa
ʻO ka lāʻau Therapeutic a me nā mea pale i hoʻolālā i ka hoʻopau ʻana i nā hōʻailona o ka maʻi ua ʻokoʻa loa. ʻAʻole lākou wale nō i ka hoʻoponopono ʻana i nā lāʻau lapaʻau, akā no ka hoʻokō pono ʻana i nā ʻōlelo a kahi mea mālama meaʻai, i ke hoʻololi ʻana i ke ʻano ola.
E makaʻala! Pono e ʻike ʻia nā ʻōlelo hoʻonaʻauao ʻole i nā lāʻau lapaʻau ʻole ʻelua me nā ʻano hoʻoilina o ka maʻi (i mea e pale ai i ka holomua), a me nā ʻano tuarua. No ka mālamaʻana i ka dyslipidemia kūloko, pono ia e hoʻopau i ke kumu kumu o kona hiki ʻana, ʻo ia hoʻi, ka maʻi mānoanoa.
ʻO ka papa inoa o nā lāʻau lapaʻau e kuhikuhi ana i ka hoʻohaʻahaʻa ʻana i ka kolamu a me kona mau ʻano like ʻole he sequestrants o nā momona bile a me nā statins, nā papa kolamu. E hoʻoponopono i nā kiʻekiʻe kiʻekiʻe o nā lipoproteins haʻahaʻa loa a me ka triglycerides, hoʻohana ʻia nā fibrates a me ka hoʻohuihui nikotinik.
ʻO nā lāʻau lapaʻau i ʻāpana o ka pūʻulu statin o ka antibiotics monocaline, ka hopena o ka mea i hoʻonui i ka pale ʻana o ka hana o ka enzyme, e hoʻonui ana i ka hana o nā keke kolamu e ka pepeka.
ʻO nā lāʻau lapaʻau Atorvastatin, Lovastatin, Pravastatin, he mahele o ka pūʻulu statin, e hoʻomohala ʻia i kēia lā e nā ala microbiological a me nā mea synthet. Hoʻohana ʻia ka mālama ʻana o dyslipidemia me nā statins i ka hoʻokaʻawale mau ʻana i ka cholesterol i ka nui ʻole wale nō i ka laulā akā akā i ka haʻahaʻa haʻahaʻa haʻahaʻa. Ke hana nui nei kēia i ka paleʻana i ka arteriosclerosis.
ʻO ka pōmaikaʻi i ka hoʻohana ʻana i nā statins ma muli o ka mālama ʻia ʻana o ka hopena, ʻaʻole ia wale nō ka hopena lipid-lowing, akā, ʻo nā hopena pleiotropic, i loko o ke ʻano o ka hoʻomaikaʻi ʻana i ka hana o ka hoʻopaʻa ʻana i nā hana maʻi i loko o nā moku.
Inā ʻaʻole lawe mai ka monotherapy me statins i kahi hopena kūpono, ʻōlelo ʻia ka lāʻau paʻakikī me ka hoʻohana ʻana i nā sequestrants o nā momona bile, no ka laʻana, Colestipol a i Cholestyramine ma loko o kahi keneta o 4 g. i ka lā maʻamau.
ʻO kēia pūʻulu o nā lāʻau lapaʻau he hopena kūpono i ka synthesis cholesterol. Hoʻolaha kēia ma ka hoʻonui ʻana i ka nui o nā waikawa bile mai ke kino a me kā lākou hoʻomau hou aʻe mai nā palaka kolamu.
ʻO ka hypertriglyceridemia hōʻailona a me ka colitis kūpaʻa piha nā contraindications i ka hoʻohanaʻana o nā kuʻi bile acid. Ma kahi hypertriglyceridemia kaʻawale, hoʻohana nā fibrates, no ka laʻana, ciprofibrate - 100 mg / lā.
Ma muli o ka hiki i kēia pūʻulu o nā lāʻau lapaʻau ke hōʻeha i nā pōhaku koleka i loko o ka lua o ka gallbladder, ʻo nā mea maʻi a pau i lawe i nā fibrates no ka manawa lōʻihi e pono ke hele i ka ultrasound maʻamau.
Hoʻopili ia, inā ʻo ka type 5 dyslipidemia i hele pū me ka pancreatitis, ʻoi aku ka maikaʻi o ka hoʻohana ʻana i ka waikū nikotinic - 2 g / lā.
Akā ʻo kēia kinona ka hopena maikaʻi ʻole i ʻae ʻia e hoʻohana i ka nui ākea o ka hoʻohana ʻana i ka acid nicotinic i ka hakakā ʻana me ka dyslipidemia. Hōʻike ʻia ka hōʻike ʻana o ke ʻano ʻulaʻula i ka ʻili o luna a me ke poʻo.
Nā manaʻo aʻoaʻo
Ke hoʻopuka nei i ka hoʻoponopono ʻia ʻana i ka meaʻai o ka mea maʻi e loaʻa ana i kekahi ʻano o ka dyslipidemia ma ke ʻano:
- ka haʻalele ʻana o ka pilikia o ka hanana a me ka holomua ʻana o nā pathologies vascular a me cardiac;
- ka hoʻonohonohoʻana o ka glucose koko;
- holomua ana i nā pae lipid;
- prophylaxis thrombophlebitis.
ʻO ka hui koʻikoʻi nui no ka dyslipidemia e hoʻopili i ka poʻe me ka mea e hoʻonui ai i ka meaʻai, no laila, ʻo ka mālamaʻana i ka hana nui ma mua o ka maʻamau o ke ʻano o ka ʻai o ka mea maʻi. Hoʻākāka nā kulekeleʻai i ka nohona o kēlā me kēia lā o ka mea maʻi me ka dyslipidemia e hoʻohālike nui i ka hoʻokomo ʻana i nā momona holoholona.
Hiki ke ʻae ʻia nā huahana ʻiʻo i ka meaʻai i hoʻokahi manawa wale nō i ka hebedoma, a i mea e hoʻonui ai i ke kino me ka protein, hoʻopau ʻia nā iʻa moana. ʻO ka papa o nā mea maʻi me nā maʻi dyslipidemic e waiwai i ka huaʻai a me nā lau ʻai i loko o nā mea nui a me nā momona.
